Fig. 3From: Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activitySerum IL-36β and IL-36γ levels in the acute and remission phases in 32 NMOSD patients. a Comparison of serum IL-36β levels between acute and remission in NMOSD patients. b Comparison of serum IL-36γ levels between acute and remission in NMOSD patients. *P < 0.05, ***P < 0.001Back to article page